Dipartimento di Scienze della Salute, Università degli Studi "Magna Graecia" di Catanzaro, Campus "Salvatore Venuta", viale Europa, 88100, Catanzaro, Italy.
Dipartimento di Scienze della Salute, Università degli Studi "Magna Graecia" di Catanzaro, Campus "Salvatore Venuta", viale Europa, 88100, Catanzaro, Italy.
Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt B):1329-1340. doi: 10.1016/j.bbagen.2016.12.023. Epub 2016 Dec 23.
Recent findings demonstrated that, in mammalian cells, telomere DNA (Tel) is transcribed into telomeric repeat-containing RNA (TERRA), which is involved in fundamental biological processes, thus representing a promising anticancer target. For this reason, the discovery of dual (as well as selective) Tel/TERRA G-quadruplex (G4) binders could represent an innovative strategy to enhance telomerase inhibition.
Initially, docking simulations of known Tel and TERRA active ligands were performed on the 3D coordinates of bimolecular G4 Tel DNA (Tel) and TERRA (TERRA). Structure-based pharmacophore models were generated on the best complexes and employed for the virtual screening of ~257,000 natural compounds. The 20 best candidates were submitted to biophysical assays, which included circular dichroism and mass spectrometry at different K concentrations.
Three hits were here identified and characterized by biophysical assays. Compound 7 acts as dual Tel/TERRA G4-ligand at physiological KCl concentration, while hits 15 and 17 show preferential thermal stabilization for Tel DNA. The different molecular recognition against the two targets was also discussed.
Our successful results pave the way to further lead optimization to achieve both increased selectivity and stabilizing effect against TERRA and Tel DNA G4s.
The current study combines for the first time molecular modelling and biophysical assays applied to bimolecular DNA and RNA G4s, leading to the identification of innovative ligand chemical scaffolds with a promising anticancer profile. This article is part of a Special Issue entitled "G-quadruplex" Guest Editor: Dr. Concetta Giancola and Dr. Daniela Montesarchio.
最近的研究结果表明,在哺乳动物细胞中,端粒 DNA(Tel)被转录为含有端粒重复序列的 RNA(TERRA),它参与了基本的生物学过程,因此是一种很有前途的抗癌靶标。出于这个原因,发现双(或选择性)Tel/TERRA G-四链体(G4)结合物可能是增强端粒酶抑制的一种创新策略。
最初,在双分子 G4 Tel DNA(Tel)和 TERRA 的 3D 坐标上进行了已知 Tel 和 TERRA 活性配体的对接模拟。在最佳复合物上生成基于结构的药效团模型,并用于对约 257000 种天然化合物进行虚拟筛选。将 20 种最佳候选物提交给包括不同 K 浓度下的圆二色性和质谱在内的生物物理测定。
通过生物物理测定,在此鉴定并表征了三个命中物。化合物 7 在生理 KCl 浓度下作为双 Tel/TERRA G4 配体,而命中物 15 和 17 则表现出对 Tel DNA 的优先热稳定性。还讨论了针对这两个靶标不同的分子识别。
我们成功的结果为进一步的先导优化铺平了道路,以实现对 TERRA 和 Tel DNA G4 的更高选择性和稳定作用。
本研究首次将分子建模和生物物理测定应用于双分子 DNA 和 RNA G4,从而鉴定出具有有前途的抗癌特性的新型配体化学支架。本文是题为“G-四链体”的特刊的一部分,客座编辑:Concetta Giancola 博士和 Daniela Montesarchio 博士。